Farallon Capital Management LLC Catalent, Inc. Transaction History

Farallon Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$32.18 - $46.57 $45.5 Million - $65.8 Million	1,413,000 New	1,413,000 $63.5 Million
Q3 2022 Nov 14, 2022	BUY	$72.36 - $113.1 $3.33 Million - $5.2 Million	46,000 Added 10.96%	465,755 $33.7 Million
Q2 2022 Aug 15, 2022	SELL	$87.2 - $114.05 $25.9 Million - $33.9 Million	-296,800 Reduced 41.42%	419,755 $45 Million
Q1 2022 May 16, 2022	SELL	$94.19 - $124.49 $4.43 Million - $5.85 Million	-47,006 Reduced 6.16%	716,555 $79.5 Million
Q4 2021 Feb 14, 2022	SELL	$119.57 - $139.07 $19.9 Million - $23.2 Million	-166,638 Reduced 17.91%	763,561 $97.8 Million
Q3 2021 Nov 15, 2021	BUY	$109.17 - $142.35 $102 Million - $132 Million	930,199 New	930,199 $124 Million

513

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Farallon Capital Management LLC with notifications on news.